Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Drell
David Drell, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110299674 | Method and Apparatus for Wideband Conferencing - A method and apparatus for wideband voice and optional data conferencing over a telecommunications network channel between at least two wideband communications devices. An exemplary method comprises establishing an audio link, verifying wideband capability between the at least two wideband communications devices, training modems of the at least two wideband communications device to line conditions, and adjusting the telecommunications connection line conditions between the communications devices. Once a wideband connection has been established, audio and data may be simultaneously exchanged. | 12-08-2011 |
William Drell US
| Patent application number | Description | Published |
|---|---|---|
| 20100087472 | USE OF METHYLNALTREXONE AND RELATED COMPOUND TO TREAT CONSTIPATION IN CHRONIC OPIOID USERS - A method of preventing or treating constipation in a patient who has been chronically taking opioids, the method comprising administering a quaternary derivative of noroxymorphone in an amount sufficient to prevent or treat the side effect in the patient, but which amount would be insufficient to treat a patient with the same opioid-induced side effect who had not chronically been administered opioids. | 04-08-2010 |
William Drell, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090312359 | USE OF METHYLNALTREXONE AND RELATED COMPOUNDS FOR TREATMENT OF GASTROINTESTINAL DYSFUNCTION INDUCED BY ENDOGENOUS OPIOIDS - A method of for preventing or treating gastrointestinal dysfunction and constipation caused by endogenous opioids in a patient who has been chronically taking opioids. The method comprises administering methylnaltrexone or another quaternary derivative of noroxymorphone most preferably by parenteral, intramuscular, intravenous or oral route. | 12-17-2009 |
